|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-6-3
|
|
pubmed:abstractText |
NY-ESO-1, a member of the cancer/testis antigen (CTA) family, elicits humoral and cellular immune responses in patients with advanced cancer. Unresectable or metastatic esophageal carcinoma patients do not benefit from the present multimodality treatment regimens in terms of survival. The objectives of this study were to analyze the antibody response to NY-ESO-1 antigen in patients with esophageal cancer and to determine the potential of NY-ESO-1 for use in tumor-specific immunotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0344-5704
|
|
pubmed:author |
pubmed-author:AkcakanatArgunA,
pubmed-author:FujiiHiroshiH,
pubmed-author:HatakeyamaKatsuyoshiK,
pubmed-author:KandaTatsuoT,
pubmed-author:KimuraEijiE,
pubmed-author:KomukaiShintarouS,
pubmed-author:KoyamaYuY,
pubmed-author:NakagawaSatoruS,
pubmed-author:OdaniShojiS,
pubmed-author:WatanabeMichitoshiM,
pubmed-author:YoshidaYutakaY
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
95-100
|
|
pubmed:dateRevised |
2006-5-13
|
|
pubmed:meshHeading |
pubmed-meshheading:15118836-Adult,
pubmed-meshheading:15118836-Aged,
pubmed-meshheading:15118836-Aged, 80 and over,
pubmed-meshheading:15118836-Antibody Formation,
pubmed-meshheading:15118836-Antigens, Neoplasm,
pubmed-meshheading:15118836-Blotting, Western,
pubmed-meshheading:15118836-Cancer Vaccines,
pubmed-meshheading:15118836-Esophageal Neoplasms,
pubmed-meshheading:15118836-Female,
pubmed-meshheading:15118836-Humans,
pubmed-meshheading:15118836-Immunohistochemistry,
pubmed-meshheading:15118836-Male,
pubmed-meshheading:15118836-Membrane Proteins,
pubmed-meshheading:15118836-Middle Aged,
pubmed-meshheading:15118836-Testis
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
NY-ESO-1 expression and its serum immunoreactivity in esophageal cancer.
|
|
pubmed:affiliation |
Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, 951-8510 Niigata, Japan.
|
|
pubmed:publicationType |
Journal Article
|
